{"id":"NCT00861757","sponsor":"Eli Lilly and Company","briefTitle":"Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia","officialTitle":"A Phase 3, Randomized, Double Blind, Placebo and Tamsulosin Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Tadalafil Once a Day Dosing for 12 Weeks in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03","primaryCompletion":"2010-06","completion":"2010-06","firstPosted":"2009-03-13","resultsPosted":"2011-06-13","lastUpdate":"2011-06-28"},"enrollment":612,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Benign Prostatic Hyperplasia"],"interventions":[{"type":"DRUG","name":"Tadalafil","otherNames":["LY450190, Cialis"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Tamsulosin","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"2.5 mg Tadalafil","type":"EXPERIMENTAL"},{"label":"5.0 mg Tadalafil","type":"EXPERIMENTAL"},{"label":"0.2 mg Tamsulosin","type":"ACTIVE_COMPARATOR"}],"summary":"This study is a randomized, double-blind, placebo and tamsulosin-controlled, parallel design, multinational study to evaluate the efficacy and safety of Tadalafil once-a-day dosing for 12 weeks in Asian men with signs and symptoms of benign prostatic hyperplasia (BPH).","primaryOutcome":{"measure":"Change From Baseline in International Prostate Symptom Score (IPSS) at 12 Weeks","timeFrame":"baseline, 12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":-3,"sd":0.4},{"arm":"2.5 mg Tadalafil","deltaMin":-4.8,"sd":0.4},{"arm":"5 mg Tadalafil","deltaMin":-4.7,"sd":0.4},{"arm":"0.2 mg Tamsulosin","deltaMin":-5.5,"sd":0.4}],"pValues":[{"comp":"OG000 vs OG001","p":"0.003"},{"comp":"OG000 vs OG002","p":"0.004"},{"comp":"OG000 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"45 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":6,"countries":["Japan","Taiwan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":154},"commonTop":["Nasopharyngitis","Myalgia","Headache","Back pain","Diarrhoea"]}}